Discontinued — last reported Q4 '25

Financing

Payment For Warrant Redemptions

This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ3 2022
Last reportedQ4 2025May 20, 2026

How to read this metric

An increase indicates active capital structure management or the exercise of redemption rights, while a decrease suggests fewer redemptions or a shift in financing strategy.

Detailed definition

Represents cash outflows associated with the repurchase or settlement of outstanding warrants. This reflects the company...

Peer comparison

Common in growth companies with complex capital structures; peers often report this as part of financing cash flows.

Metric ID: financing_payment_for_warrant_redemptions

Historical Data

12 periods
 Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$10.25K$10.25K$10.25K$10.25K$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change+0.0%+0.0%+0.0%-100.0%
YoY Change-100.0%-100.0%
Range$0.00$10.25K
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Roivant Sciences's payment for warrant redemptions?
Roivant Sciences (ROIV) reported payment for warrant redemptions of $0.00 in Q1 2026.
What does payment for warrant redemptions mean?
Cash paid to buy back or settle company warrants.